Back to Authors

Zamanian, Roham T.

Mayo Clinic

Pulmonary and Allergy Associates

Citations 1

Angiotensin Converting Enzyme Inhibition and Mortality in Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH‐COPD)
Yogeswaran, Athiththan , Fünderich, Meike , Wendlandt, Katharina, Annis, Jeffrey , Brittain, Evan, Eichstaedt, Christina A., Cajigas, Héctor , Frantz, Robert P. , Sweatt, Andrew J. , Zamanian, Roham T., Wilhelm, J, Ghofrani, Hossein-Ardeschir, Tello, Khodr , Thenappan, Thenappan , Balasubramanian, Aparna , Sіrenko, Yu.M. , Cajigas, Hector R , Frantz, Robert P , Tello, Khodr , Seeger, Werner , Thenappan, Thenappan , Yogeswaran, Athiththan , Balasubramanian, Aparna , Eichstaedt, Christina A. , Grünig, Ekkehard , Zamanian, Roham T. , Grimminger, Friedrich , Wilhelm, Jochen, Ghofrani, Hossein Ardeschir , Seeger, Werner

Pulmonary Circulation | July 16, 2026 | Volume: 16 | Issue: 3 | Pages: No page available

10.1002/pul2.70348 Get It

ABSTRACT In 567 PH‐COPD patients from the PVRI GoDeep Meta‐Registry, ACE inhibitor use was associated with improved survival only in severe PH (PVR > 5 WU), supporting prospective trials targeting this high‐risk subgroup.